default search action
"Cystatin C as a biomarker for cardiorenal syndrome diseases quantitative ..."
Xushuo Zhang et al. (2022)
- Xushuo Zhang, Sam Jeffery Fishlock, Peter Sharpe, James McLaughlin:
Cystatin C as a biomarker for cardiorenal syndrome diseases quantitative diagnostics and monitoring via point-of-care. EMBC 2022: 1428-1431
manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.